What weight loss treatment options do geriatric patients with overweight and obesity want to consider?

INTRODUCTION: Since the 1990s, a number of weight loss medications have been removed from the USA and or European market because of adverse events associated with these medications. These medications include fenfluramine (heart valve thickening), sibutramine (cardiovascular risk) and rimonabant (dep...

Descripción completa

Detalles Bibliográficos
Autores principales: MacMillan, M., Cummins, K., Fujioka, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192535/
https://www.ncbi.nlm.nih.gov/pubmed/28090354
http://dx.doi.org/10.1002/osp4.66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192535/
https://www.ncbi.nlm.nih.gov/pubmed/28090354
http://dx.doi.org/10.1002/osp4.66

Ejemplares similares